Study 4 of 13PT-141 (Bremelanotide) literatureSemanticScholar2010
Semantic Scholar search for PT-141 (Bremelanotide)
Not reported in abstract.
Where it sits
this study against the rest of the pt-141 (bremelanotide) corpus5
Preclinical · this one
3
Observational
1
Open-label
1
Randomised
3
Reviews
Summary and findings
Not reported in abstract.
How much of this paper we could read: title only (0.00). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2010
Background
Not reported in abstract.
Methods
Not reported in abstract.
Results
Not reported in abstract.
Interpretation
Not reported in abstract.
Key findings
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Limitations
- Not reported in abstract.
- Not reported in abstract.
- Not reported in abstract.
Elsewhere in the PT-141 (Bremelanotide) corpus
ASafety, tolerability, and pharmacokinetics/-dynamics of the dipeptidyl peptidase 3-inhibiting antibody Procizumab in a first-in-human trial.mAbs · 2026 · Terminal elimination half-life of 24 h (3 mg/kg), 34 h (6 mg/kg), and 53 h (12 mg/kg).HumanCPreclinical safety evaluation of the dipeptidyl peptidase 3 inhibiting antibody Procizumab in rodents and non-human primates.mAbs · 2026 · 150 mg/kg PCZ in mice, n=126; 350 mg/kg PCZ in monkeys, n=10.AnimalBRisk stratification for in-hospital mortality in sepsis-associated acute kidney injury patients receiving continuous renal replacement therapy: an interpretable, externally validated machine learning study.Renal failure · 2026 · AUC of 0.890 in training cohort, n=1217.HumanDComprehensive characterization of bremelanotide acetate and its degradants by LC-HRMS/MS and predicting epimerization through computational modelling.Analytical methods : advancing methods and applications · 2026 · Coefficient of determination (r²) of 0.9993 over the concentration range of 25-150 µg mL-1.—CIncorporation of Three Extracyclic Arginine Residues into a Melanocortin Macrocyclic Agonist (c[Pro-His-DPhe-Arg-Trp-Dap-Lys(Arg-Arg-Arg-Ac)-DPro]) Decreases Food Intake When Administered Intrathecally or Subcutaneously Compared to a Macrocyclic Ligand Lacking Extracyclic Arginine Residues (c[Pro-His-DPhe-Arg-Trp-Dap-Ala-DPro)].ACS pharmacology & translational science · 2024 · n=30 · Not reported in abstract.AnimalBQuantification of "Mercy Sex" in Heterosexual Women.PubMed · 2026 · Women engaged in 'mercy sex' approximately 2.5 times/month.Human